Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Capricor Therap (CAPR)

Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 675,684
  • Shares Outstanding, K 45,470
  • Annual Sales, $ 25,180 K
  • Annual Income, $ -22,290 K
  • EBIT $ -36 M
  • EBITDA $ -35 M
  • 60-Month Beta 3.98
  • Price/Sales 26.24
  • Price/Cash Flow N/A
  • Price/Book 9.66

Options Overview Details

View History
  • Implied Volatility 158.72% ( -0.05%)
  • Historical Volatility 112.16%
  • IV Percentile 92%
  • IV Rank 48.24%
  • IV High 279.80% on 09/20/24
  • IV Low 45.85% on 05/15/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 417
  • Volume Avg (30-Day) 3,799
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 84,273
  • Open Int (30-Day) 77,093

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.37
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -1,550.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.51 +19.90%
on 12/04/24
20.75 -27.71%
on 12/03/24
-4.70 (-23.86%)
since 11/08/24
3-Month
4.05 +270.37%
on 09/12/24
23.40 -35.90%
on 10/15/24
+10.80 (+257.14%)
since 09/09/24
52-Week
3.24 +362.31%
on 12/11/23
23.40 -35.90%
on 10/15/24
+11.31 (+306.50%)
since 12/08/23

Most Recent Stories

More News
Capricor Therapeutics to Present at Piper Sandler and Oppenheimer Investor Conferences in December 2024

Capricor Therapeutics announces presentations at upcoming investor conferences regarding its exosome-based therapeutics and clinical developments.Quiver AI SummaryCapricor Therapeutics announced its participation...

CAPR : 15.01 (+1.01%)
Capricor Therapeutics to Present at Upcoming Investor Conferences

CAPR : 15.01 (+1.01%)
Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

CAPR : 15.01 (+1.01%)
Capricor: Q3 Earnings Snapshot

Capricor: Q3 Earnings Snapshot

CAPR : 15.01 (+1.01%)
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

CAPR : 15.01 (+1.01%)
Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting

CAPR : 15.01 (+1.01%)
Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

CAPR : 15.01 (+1.01%)
Insider Stock Research: New Fortress Energy, Marvell, and More

October has seen a flurry of insider trading activity across multiple sectors, with key executives making significant stock purchases. New Fortress Energy’s (

PLAY : 36.06 (-2.14%)
DKL : 39.44 (+0.61%)
RNAC : 25.59 (+1.79%)
COHR : 105.76 (-4.93%)
NEOG : 13.26 (+3.43%)
WOR : 41.69 (+2.11%)
NFE : 13.14 (+5.88%)
STTK : 1.3600 (+8.80%)
MRVL : 107.96 (-4.89%)
CAPR : 15.01 (+1.01%)
Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

CAPR : 15.01 (+1.01%)
Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

CAPR : 15.01 (+1.01%)

Business Summary

Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based...

See More

Key Turning Points

3rd Resistance Point 16.49
2nd Resistance Point 16.03
1st Resistance Point 15.44
Last Price 15.01
1st Support Level 14.39
2nd Support Level 13.93
3rd Support Level 13.34

See More

52-Week High 23.40
Fibonacci 61.8% 15.70
Last Price 15.01
Fibonacci 50% 13.32
Fibonacci 38.2% 10.94
52-Week Low 3.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar